TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
Holding TLSI?
Track your performance easily

TriSalus Life Sciences (TLSI) Financial Statements

24 Followers

TriSalus Life Sciences Financial Overview

TriSalus Life Sciences's market cap is currently ―. The company's EPS TTM is $-2.511; its P/E ratio is -1.78; TriSalus Life Sciences is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.36M$ 6.46M$ 13.32M$ 5.19M-
Gross Profit$ 6.45M$ 5.49M$ 11.30M$ 4.60M-
EBIT$ -3.45M$ -13.21M$ -56.36M$ -1.28M$ -952.32K
EBITDA$ -2.76M$ -12.95M$ -56.16M$ -782.00K$ -952.32K
Net Income Common Stockholders$ -5.13M$ -14.02M$ -51.31M$ -1.29M$ -995.04K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.48M$ 3.97M$ 11.78M$ 21.38M$ 103.97K
Total Assets$ 32.43M$ 17.89M$ 25.73M$ 33.55M$ 12.24M
Total Debt$ 21.29M$ 0.00$ 0.00$ 0.00$ 1.57M
Net Debt$ 4.80M$ -3.97M$ -11.78M$ -21.38M$ 1.47M
Total Liabilities$ 56.58M$ 52.81M$ 51.66M$ 25.07M$ 15.31M
Stockholders Equity$ -24.15M$ -34.92M$ -25.94M$ 8.49M$ -15.12M
Cash Flow-
Free Cash Flow$ -13.48M$ -10.93M$ -9.55M$ -40.60M$ -313.90K
Operating Cash Flow$ -13.42M$ -10.87M$ -8.85M$ -40.18M$ -313.90K
Investing Cash Flow$ -60.00K$ -66.00K$ -700.00K$ -9.54M$ 8.36M
Financing Cash Flow$ 25.99M$ 3.13M$ 43.00K$ 61.74M$ -8.07M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

TriSalus Life Sciences Debt to Assets

TriSalus Life Sciences Cash Flow

TriSalus Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis